Axinn partner Chad Landmon's presentation during the Food and Drug Law Institute's annual meeting was mentioned in FDLI's Update article, "Drugs and Biologics: New Administration, New Legislation, New Precedents."

Click here to access the article.*  FDLI membership is required to view the article.